• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

New Therapeutic Modalities in Prion Diseases.

作者信息

Pettinari Alberto, Uliassi Elisa, Bolognesi Maria Laura

机构信息

Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Bologna, Italy.

出版信息

Subcell Biochem. 2025;112:39-64. doi: 10.1007/978-3-031-97055-9_3.

DOI:10.1007/978-3-031-97055-9_3
PMID:41004053
Abstract

Prion diseases are fatal neurodegenerative disorders for which no effective therapies exist. Despite decades of drug discovery efforts, progress in developing disease-modifying treatments has been slow. However, recent advances have introduced novel therapeutic modalities targeting key aspects of prion pathology, including prion protein biogenesis, aggregation, and degradation. Advancements in diagnostic tools and highly sensitive prion detection methods are also playing a crucial role in enabling early and accurate diagnosis, which is essential for the timely application of emerging therapeutics. This chapter explores novel therapeutic modalities for prion diseases, focusing on small-molecule theranostics and compounds promoting prion protein degradation, RNA-based therapeutics, and gene therapy approaches. We critically assess the advantages and limitations of these therapeutic strategies, considering their development, efficacy, and translational potential. By leveraging these innovative modalities, the therapeutic toolbox for prion diseases is expanding, offering hope for the development of effective treatments.

摘要

相似文献

1
New Therapeutic Modalities in Prion Diseases.
Subcell Biochem. 2025;112:39-64. doi: 10.1007/978-3-031-97055-9_3.
2
Therapeutic Trajectories in Human Prion Diseases.
Subcell Biochem. 2025;112:91-113. doi: 10.1007/978-3-031-97055-9_5.
3
Shoulder Arthrogram肩关节造影
4
Prions and prion diseases: Insights from the eye.朊病毒与朊病毒病:眼部相关新视角。
Exp Eye Res. 2020 Oct;199:108200. doi: 10.1016/j.exer.2020.108200. Epub 2020 Aug 25.
5
Vesicoureteral Reflux膀胱输尿管反流
6
A review on current theories and potential therapies for prion diseases.朊病毒疾病的当前理论与潜在治疗方法综述。
Mol Biol Rep. 2025 Jul 4;52(1):674. doi: 10.1007/s11033-025-10754-2.
7
Human Genetic Evidence for New Targets in Prion Diseases: Opportunities and Challenges.朊病毒疾病新靶点的人类遗传证据:机遇与挑战
Subcell Biochem. 2025;112:219-244. doi: 10.1007/978-3-031-97055-9_10.
8
[Systematic review of the therapeutics for prion diseases].[朊病毒疾病治疗方法的系统评价]
Brain Nerve. 2009 Aug;61(8):929-38.
9
A comprehensive phylogeny of mammalian PRNP gene reveals no influence of prion misfolding propensity on the evolution of this gene.哺乳动物PRNP基因的综合系统发育分析表明,朊病毒错误折叠倾向对该基因的进化没有影响。
PLoS Pathog. 2025 Jun 25;21(6):e1013257. doi: 10.1371/journal.ppat.1013257. eCollection 2025 Jun.
10
Human PrP E219K: a new and promising substrate for robust RT-QuIC amplification of human prions with potential for strain discrimination.人源PrP E219K:一种用于人朊病毒高效RT-QuIC扩增的新型且有前景的底物,具有区分毒株的潜力。
Microbiol Spectr. 2025 Jul 10:e0029225. doi: 10.1128/spectrum.00292-25.

本文引用的文献

1
In silico analysis of aptamer-RNA conjugate interactions with human transferrin receptor.与人类转铁蛋白受体的适体-RNA 缀合物相互作用的计算机分析。
Biophys Chem. 2024 Nov;314:107308. doi: 10.1016/j.bpc.2024.107308. Epub 2024 Aug 10.
2
The importance of prion research.朊病毒研究的重要性。
Biochem Cell Biol. 2024 Dec 1;102(6):448-471. doi: 10.1139/bcb-2024-0018. Epub 2024 Jul 12.
3
Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor.通过 AAV 介导的工程化紧凑表观遗传编辑器,实现全脑朊病毒蛋白沉默。
Science. 2024 Jun 28;384(6703):ado7082. doi: 10.1126/science.ado7082.
4
Aptamer Technologies in Neuroscience, Neuro-Diagnostics and Neuro-Medicine Development.适体技术在神经科学、神经诊断和神经医学发展中的应用。
Molecules. 2024 Mar 2;29(5):1124. doi: 10.3390/molecules29051124.
5
Creutzfeldt-Jakob disease and other prion diseases.克雅氏病及其他朊病毒病。
Nat Rev Dis Primers. 2024 Feb 29;10(1):14. doi: 10.1038/s41572-024-00497-y.
6
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders.反义寡核苷酸疗法治疗单基因疾病的可能性与局限性。
Commun Med (Lond). 2024 Jan 5;4(1):6. doi: 10.1038/s43856-023-00419-1.
7
Tominersen in Adults with Manifest Huntington's Disease.托米森用于有明显亨廷顿舞蹈病的成人患者。
N Engl J Med. 2023 Dec 7;389(23):2203-2205. doi: 10.1056/NEJMc2300400.
8
A new age of precision gene therapy.精准基因治疗的新时代。
Lancet. 2024 Feb 10;403(10426):568-582. doi: 10.1016/S0140-6736(23)01952-9. Epub 2023 Nov 22.
9
Breaking barriers with tofersen: Enhancing therapeutic opportunities in amyotrophic lateral sclerosis.托法替布:突破肌萎缩侧索硬化症治疗困境的新希望。
Eur J Neurol. 2024 Feb;31(2):e16140. doi: 10.1111/ene.16140. Epub 2023 Nov 17.
10
A single-cell map of antisense oligonucleotide activity in the brain.反义寡核苷酸在大脑中的活性的单细胞图谱。
Nucleic Acids Res. 2023 Aug 11;51(14):7109-7124. doi: 10.1093/nar/gkad371.